Literature DB >> 24223350

Comparison between the Effects of Rocuronium, Vecuronium, and Cisatracurium Using Train-of-Four and Clinical Tests in Elderly Patients.

Ozlem Sagir1, Funda Yucesoy Noyan, Ahmet Koroglu, Muslum Cicek, Huseyin Ilksen Toprak.   

Abstract

BACKGROUND: Postoperative residual blockade, longer duration of action for neuromuscular blockade, and slower recovery were relatively common in elderly patients.
OBJECTIVES: We aimed to investigate the safety of train-of-four ratio and clinical tests in the assessment of patient recovery, and to determine the effects of the rocuronium, vecuronium, and cisatracurium on intubation, extubation and recovery times in elderly patients undergoing abdominal surgery. PATIENTS AND METHODS: After obtaining institutional approval and informed consent, 60 patients over 60 years old and undergoing elective abdominal operations were included in this double-blind, randomized clinical trial. Following a standard anesthesia induction, 0.6mg kg-1 rocuronium, 0.1mg kg-1 vecuronium, and 0.1mg kg-1 cisatracurium were administered to the patients in Group R, Group V, and Group C, respectively. Train-of-four (TOF) ratios were recorded at 10-minute intervals during and after the operation. Modified Aldrete Score (MAS) and clinical tests were recorded in the recovery room at 10-minute intervals. In addition, intubation and extubation times, duration of recovery room stay, and any complications were recorded.
RESULTS: Intubation time was found to be shorter in Group R than that in Groups V and C (P ˂ 0.001). Times to positive visual disturbances and grip strength tests were shorter in Group C than that in Group V (P = 0.016 and P = 0.011, respectively). In Group R and group C, time to TOF ≥ 0.9 was significantly longer than all positive clinical test times except grip strength (P < 0.05).
CONCLUSIONS: We hold the opinion that cisatracurium is safer in elderly patients compared to other drugs. We also concluded that the usage of TOF ratio together with clinical tests is suitable for assessment of neuromuscular recovery in these patients.

Entities:  

Keywords:  Aged; Cisatracurium; Neuromuscular Blockade; Rocuronium; Vecuronium Bromide

Year:  2013        PMID: 24223350      PMCID: PMC3821141          DOI: 10.5812/aapm.8406

Source DB:  PubMed          Journal:  Anesth Pain Med        ISSN: 2228-7523


  28 in total

1.  Residual paralysis at the time of tracheal extubation.

Authors:  Glenn S Murphy; Joseph W Szokol; Jesse H Marymont; Mark Franklin; Michael J Avram; Jeffery S Vender
Journal:  Anesth Analg       Date:  2005-06       Impact factor: 5.108

2.  Postoperative residual paralysis in outpatients versus inpatients.

Authors:  Guy Cammu; Jan De Witte; Jan De Veylder; Geert Byttebier; Dirk Vandeput; Luc Foubert; Geert Vandenbroucke; Thierry Deloof
Journal:  Anesth Analg       Date:  2006-02       Impact factor: 5.108

3.  Prolonged residual paralysis after a single intubating dose of rocuronium.

Authors:  C Claudius; H Karacan; J Viby-Mogensen
Journal:  Br J Anaesth       Date:  2007-08-03       Impact factor: 9.166

4.  Recovery from neuromuscular blockade: a survey of practice.

Authors:  M Grayling; B P Sweeney
Journal:  Anaesthesia       Date:  2007-08       Impact factor: 6.955

5.  Assessment of neuromuscular and haemodynamic effects of cisatracurium and vecuronium under sevoflurane-remifentanil anaesthesia in elderly patients.

Authors:  G T Keleş; A Yentür; Z Cavuş; M Sakarya
Journal:  Eur J Anaesthesiol       Date:  2004-11       Impact factor: 4.330

6.  Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients.

Authors:  V Slavov; M Khalil; J C Merle; M M Agostini; R Ruggier; P Duvaldestin
Journal:  Br J Anaesth       Date:  1995-06       Impact factor: 9.166

7.  Postoperative residual curarization with cisatracurium and rocuronium infusions.

Authors:  G Cammu; L de Baerdemaeker; N den Blauwen; J C de Mey; M Struys; E Mortier
Journal:  Eur J Anaesthesiol       Date:  2002-02       Impact factor: 4.330

8.  The effects of magnesium sulfate on neuromuscular blockade by cisatracurium during induction of anesthesia.

Authors:  Mohammad R Ghodraty; Amir A Saif; Ali R Kholdebarin; Faranak Rokhtabnak; Ali R Pournajafian; Ali R Nikzad-Jamnani; Anjan Shah; Nader D Nader
Journal:  J Anesth       Date:  2012-07-03       Impact factor: 2.078

Review 9.  Selecting neuromuscular-blocking drugs for elderly patients.

Authors:  Tristan M Cope; Jennifer M Hunter
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Assessing residual neuromuscular blockade using acceleromyography can be deceptive in postoperative awake patients.

Authors:  Christophe Baillard; Sylvie Bourdiau; Philippe Le Toumelin; Farid Ait Kaci; Bruno Riou; Michel Cupa; C Marc Samama
Journal:  Anesth Analg       Date:  2004-03       Impact factor: 5.108

View more
  5 in total

1.  Comparison of equipotent doses of rocuronium and vecuronium.

Authors:  Mrunalini Parasa; Nagendra Nath Vemuri; Mastan Saheb Shaik
Journal:  Anesth Essays Res       Date:  2015 Jan-Apr

2.  Effective doses of cisatracurium in the adult and the elderly.

Authors:  Jeong Ho Kim; Yoon Chan Lee; Soo Il Lee; Sang Yoong Park; So Ron Choi; Jong Hwan Lee; Chan Jong Chung; Seung Cheol Lee
Journal:  Korean J Anesthesiol       Date:  2016-09-08

3.  Grip strength can be used to evaluate postoperative residual neuromuscular block recovery in patients undergoing general anesthesia.

Authors:  Da-Qing Pei; Hong-Mei Zhou; Qing-He Zhou
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

Review 4.  Neuromuscular blockade in the elderly patient.

Authors:  Luis A Lee; Vassilis Athanassoglou; Jaideep J Pandit
Journal:  J Pain Res       Date:  2016-06-17       Impact factor: 3.133

5.  Efficacy and Safety of Neuromuscular Blockade in Overweight Patients Undergoing Nasopharyngeal Surgery.

Authors:  Lingxia Niu; Yu Wang; Chunlin Yao; Yan Sun; Shanglong Yao; Yun Lin
Journal:  Med Sci Monit       Date:  2020-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.